These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 17040922

  • 1. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL.
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [Abstract] [Full Text] [Related]

  • 2. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
    Alder J.
    Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
    [Abstract] [Full Text] [Related]

  • 3. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
    Skiest DJ.
    J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
    [Abstract] [Full Text] [Related]

  • 4. Who's winning the war?
    Gould IM.
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii3-6. PubMed ID: 18829723
    [Abstract] [Full Text] [Related]

  • 5. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS, McDermott BP, Cunha BA.
    Heart Lung; 2005 Nov; 34(1):69-71. PubMed ID: 15647736
    [Abstract] [Full Text] [Related]

  • 6. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
    Vikram HR, Havill NL, Koeth LM, Boyce JM.
    J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
    [Abstract] [Full Text] [Related]

  • 7. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.
    Carpenter CF, Chambers HF.
    Clin Infect Dis; 2004 Apr 01; 38(7):994-1000. PubMed ID: 15034832
    [Abstract] [Full Text] [Related]

  • 8. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA.
    J Antimicrob Chemother; 2008 Nov 01; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [Abstract] [Full Text] [Related]

  • 9. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI, Mejías A, Katz KS, Revell P, McCracken GH, Sánchez PJ.
    Pediatr Infect Dis J; 2007 Dec 01; 26(12):1128-32. PubMed ID: 18043450
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ.
    Clin Microbiol Infect; 2006 Mar 01; 12 Suppl 1():24-32. PubMed ID: 16445721
    [Abstract] [Full Text] [Related]

  • 11. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F, Aguilar L, González N, Giménez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J.
    J Antimicrob Chemother; 2007 Jun 01; 59(6):1185-9. PubMed ID: 17412725
    [Abstract] [Full Text] [Related]

  • 12. Methicillin-resistant Staphylococcus aureus: the superbug.
    Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP.
    Int J Infect Dis; 2010 Oct 01; 14 Suppl 4():S7-11. PubMed ID: 20851011
    [Abstract] [Full Text] [Related]

  • 13. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN.
    Clin Microbiol Infect; 2008 Mar 01; 14 Suppl 2():3-9. PubMed ID: 18226084
    [Abstract] [Full Text] [Related]

  • 14. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
    Pangercić A, Bukovski-Simonoski S, Barsić B.
    Lijec Vjesn; 2010 Mar 01; 132 Suppl 1():11-3. PubMed ID: 20715711
    [Abstract] [Full Text] [Related]

  • 15. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST.
    Clin Infect Dis; 2007 Sep 15; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD, Citron DM.
    Diagn Microbiol Infect Dis; 2010 Apr 15; 66(4):441-4. PubMed ID: 20226335
    [Abstract] [Full Text] [Related]

  • 17. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G, Moellering RC.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [Abstract] [Full Text] [Related]

  • 18. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F, Beiras-Fernandez A, Schelling G.
    Curr Opin Investig Drugs; 2008 Aug 01; 9(8):879-84. PubMed ID: 18666036
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ, Lamp KC.
    Curr Med Res Opin; 2006 Dec 01; 22(12):2337-43. PubMed ID: 17257448
    [Abstract] [Full Text] [Related]

  • 20. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
    Steenbergen JN, Alder J, Thorne GM, Tally FP.
    J Antimicrob Chemother; 2005 Mar 01; 55(3):283-8. PubMed ID: 15705644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.